Abstract
Introduction
Congenital anomalies are recognised in 2-3% of newborn babies 1 . Anomalies are more common in pregnancies with diabetes, among aborted foetus, pre-term and still-born infants. Birth defects are the leading cause of infant deaths in USA 2 . In past, anomalies were responsible for 10% of all perinatal deaths. Now with the reduction of other causes malformation accounts for 30-50% of perinatal mortality. In worldwide studies incidence of major malformation among off-springs of IDDM (insulin dependant diabetes mellitus) mothers ranges from 5-10 % 3 . 20-25% congenital malformations are the result of chromosomal abnormalities or single gene defect. 65-75% of birth defects are due to multiple causes such as maternal infections (e.g. CMV, syphilis, rubella, toxoplasma), maternal disease (e.g. diabetes, epilepsy, alcohol abuse), exposure to drugs (alcohol, thalidomide, folic acid antagonist, DES, androgen, anticonvulsant, high dose of vitamin A, synthetic oestrogen, radioactive iodine etc.) and radiation 2 .
The cause of diabetic embryopathy is not fully understood. Maternal hyperglycaemia has proposed by most investigators as primary teratogenic factor but various factors are related such as hyperketonaemia, hypoglycaemia, somatomedin inhibitor excess, excess free radical production, reduced intracellular myoinositol, arachidonic acid deficiency, yolk sac failure and maternal vasculopathy 4 . Profile of a woman most likely to produce an anomalous infant would include a patient with poor periconceptional diabetic control, long standing diabetes with vasculopathy. Genetic susceptibility to the teratogenic influence of diabetes may be a factor. However, teratogenic effect of hyperglycaemia has been suggested by human study and has been confirmed by animal study 5 .
Prior to the advent of insulin co-existence of DM with successful pregnancy was a rare event. William reported maternal mortality of 30% and perinatal loss of 70% in 1909. Discovery of insulin in 1921 changed the outlook for the pregnant patient completely. Maternal mortality was reduced to nil and perinatal mortality to 3-5 % over the years. High incidence of congenital malformation of about 12% is reduced to 5-6 % by pre-pregnancy counseling and control of diabetes. In pre-gestational diabetes, foetal mortality and morbidity occurs more than in gestational diabetes (GDM) 6 .
Poor diabetic control predisposes congenital malformation, particularly of CNS, cardiac and renal systems. It occurs 3 to 4 times more commonly than in non-diabetic woman 7 .
In one study the prevalence of major anomalies in the offspring of diabetic mother was 46 per 1000 total births. This compares with 21 per 1000 total birthsfrom the EUROCAT data for 2002 (prevalence ratio 2.2, 95% confidence interval 1.8 to 2.6; P < 0.001). The prevalence of major anomalies associated with type 1 diabetes was 48 per 1000 total births, and the prevalence associated with type 2 diabetes was 43 per 1000 total births. Statistically significant increases were confined to anomalies of the nervous system (prevalence ratio 2.7, 1.5 to 4.4; P <0.001) and congenital heart disease (prevalence ratio 3.4, 2.5 to 4.6; P < 0.001). The increase in anomalies of the nervous system was driven by an increase in the observed number of neural tube defects (prevalence ratio 4.2, 2.0 to 7.8; P < 0.001) 11 .
Sacral agenesis and caudal regression syndrome is almost pathognomonic of diabetes and occurs 256 times more often in diabetic than non-diabetic 13 .
Rapid development of techniques allowing early and accurate pre-natal diagnosis of foetal disorder reduces the rate of congenital anomaly among newborn babies. Antenatal diagnosis of some cardiac conditions decreases the risk of neonatal mortality 8 . Routine ultrasound scanning foranomalies in the UK has been reported to identify 23% of cardiac defects 9 . Implementing specialist views of the fetal heart may increase the pick-up rate of cardiac anomalies up to 75% 14 . This study showed that cardiac lesions were the most frequent anomaly in the off spring of women with diabetes and 55% were detected ante-natally. If blood glucose concentration during diabetic pregnancy is maintained near normal level and available techniques for assessment of foetal growth and well-being are used appropriately, then a pregnancy outcome approaching that of non-diabetic mother can be achieved 15 . Congenital malformation developed during early gestational period. So its prevention necessitate preconceptional care. In 14 cohort studies, major congenital malformation swere assessed among 1192 off spring of mothers who had received preconception care and 1459 off spring of women who had not. The pooled rate of major anomalies was lower among preconceptioncare recipients (2.1%) than non-recipients (6.5%) (RR 0.36,95% CI 0.22-0.59) 16 .
The aim of my study is to see the actual picture of congenital anomaly among diabetic mothers in our BIRDEM hospital and the association of poorly controlled DM with occurrence of congenital anomaly. My study will provide information to doctors, help them in pre-natal counseling and thus reduce the rate of occurrence of birth defects among babies of diabetic mothers.
Materials & Methods
This cross -sectional study was done in the Department of obstetrics and gynaecology in BIRDEM hospital, Dhaka from, January, 2006 to December, 2010. Permission was taken from the concerned Department & authorities after getting recommendation of ethical committee. Informed consent was taken from all the study subjects after full explanation of nature and purpose of study. Total 163 subjects of age ranged from 20 -40 years were selected from the Department of Obs & Gynae and also from SCABU of same institute detail record files were searched to collect all data. Study subjects were selected according to inclusion and exclusion criteria Exclusion criteria were age >40 years, patients having congenital heart disease, patients with known autoimmune disorder like SLE, Hypothyroidism etc, patients with history of exposure to radiation, patients with history of teratogenic drugs taking. Inclusion criteria were after exclusion of above patients, all women who delivered congenitally abnormal babies in BIRDEM hospital and the mothers whose congenitally abnormal babies admitted in SCABU in same hospital. Sample were selected randomly according toinclusion and exclusion criteria. All data were checked and edited after collection. Then the data were entered into the computer and analyzed with the help of SPSS 12 program me.
Results
Among the mothers of congenitaly abnormal babies, maximum (58.3%) and among them 3.5% gave history of previous congenitally abnormal babies. Blood sugarwas found uncontrolledin 82.5% of diabetic and 89.5% are gestational diabetic patient. Among diabetic patient HbAIc was raised more indiabetic than gestational diabetes (96.5% versus 84.2%.
Multiple types of congenital anomalies was found and maximum was cardiac and CNS related. Among CNS anomalies hydrocephalus, meningocele and anencephaly was found. Table II shows the history of congenitally abnormal baby in previous pregnancy. In the study population only in DM group 2 patients [3.50%] had the history of congenitally abnormal baby in previous pregnancy. 
Blood sugar level
The American College of Obstetricians and Gynecologists (ACOG) recommends that women with pregestational diabetes maintain fasting plasma glucose levels between 60-90 mg/dL and 2-hour postprandial levels <120 mg/dL 8 . For women with gestational diabetes who are not controlled within these targets on dietary therapy alone, ACOG recommends the additional of insulin therapy 9 .
The American Diabetes Association recommends that women with pregestational diabetes maintain capillary plasma glucose levels of 80-110 mg/dL before and <155 mg/dL 2 hours after meals before pregnancy and while trying to conceive 10 . The ADA does not list target glucose level for women with pregestational diabetes once they become pregnant. The ADA recommends the use of diet and insulin therapy to maintain preprandial plasma glucose levels of <105 mg/dL and 2-hour postprandial levels below <130 mg/dL in gestational diabetes.
In our study we followed ADA criteria for the target of control blood suger level during pregnancy. So, controlled are grouped as fasting < 6.1 mmol/L [105 mg/dl] and post prandial < 7.6 mmol/L [130mg/dl].
Among 57 diabetic patients only 10 patents [17.5%] had controlled blood sugar level. Among 38 GDM patients 4 patients [10.5%] had controlled blood sugar level. So, it is clear that congenital anomalies are more common among the uncontrolled group. Rosenn and Tsang (1991) summarize several studies with compared incidences of congenital malformations in women with poor versus good control. The rate of birth defects among women with poor control ranges from 4.5% -35.3%. However, with good glycaemic control, these risks are greatly reduced with a range from 0% -10.7%.
HbA1c level
Among 57 diabetic patients only 55 patents [96.5%] had HbA1c level above normal level. In case of GDM patients it was 84.2%. Study done by Marry C M Macintosh et al showed that good control def ined by glycosylatedhaemoglobin (HbA1c) of less than 7%, was achieved by 596 (37%) women. The median HbA1c was 7.9% for the women whose pregnancies resulted in a congenital anomaly. The result is similar to my study. In another study shows that, when the frequency of congenital anomalies in patients with normal or high firsttrimester maternal glycosylated hemoglobin values was compared to the frequency in healthy patients, the rate of anomalies was only 3.4% with glycosylated hemoglobin (HbA1C) values of less than 8.5%, whereas patients with poorer glycemic control in the periconceptional period (HbA1C>8.5%) had a 22.4% rate of malformations. An overall malformation rate of 13.3% was reported in 105 patients with diabetes, but the risk of delivering an infant who is malformed was comparable to a normal population when the HbA1C value was less than 7%. 
ORIGINAL ARTICLE
BMI, prior pregnancy with macrosomia, stillbirth or anomalies) and clinical parameter (gestational age at first prenatal visit, first trimester exposure to sulfonylurea agents) and value of the initial fasting glucose and HbA1c were investigated regarding their relation to anomalies. 143 infants (3.4%) with major anomalies were identified, with a prevalence of 2.9% in GDM and 8.9% in type 2 diabetes. The most frequently affected organ systems were cardiac (37.6%), musculo-skeletal (16%) and nervous system (9.8%).
In conclusion, DM in mother has been suggested an important risk factor for the development of congenital anomalies among the offspring. Mills [1988] reported rate of major malformation 2-3 times greater in infants of IDDM mother 3 even 10 times when DM is severe at conception. Others had found the rate of anomalies in offspring of diabetic women to be 2-5 times greater than the general population. The overall rate of congenital anomalies in infants born to diabetic mothers may be as high as 10% when there is not good glycemic control. The prevalence of malformations appears to increase with more severe degrees of diabetic disease 04 Mary C.M. Macintosh et al seen the risk of major congenital anomalies in the offspring of women with diabetes was more than two fold increased than in general population 17 . In our study we have found major anomalies are about 1.2 times more in diabetic patients. In our study most diabetic patients had uncontrolled blood sugar [96.5% in DM and 84.2% in GDM] and HbA1c level more than normal limit [> 7%]. Rosenn and Tsang (1991) summarize several studies with compared incidences of congenital malformations in women with poor versus good control. The rate of birth defects among women with poor control ranges from 4.5% -35.3%. However, with good glycaemic control, these risks are greatly reduced with a range from 0% -10.7%. As most of the anomalies of the foetus occur between 4 th to 7 th weeks of gestation after conception, so periconceptional diabetic control is important. In preconceptional care [in diabetic patients] strict blood sugar control is advised. In one study major congenital anomalies were lower among pre-conception care recipients [2.1%] than non-recipients [6.5%]. In 14 cohort studies, major congenital malformations were assessed among 1192 off spring of mothers who had received preconception care, and 1459 offspring of women who had not. The pooled rate of major anomalies was lower among preconception care recipients (2.1%) than non-recipients (6.5%) (RR 0.36, 95% CI 0.22-0.59). In nine studies, the risk for major and minor anomalies was also lower among women who received preconception care (RR 0.32, 95% CI 0.17-0.59) 15 . We found commonest anomalies were cardiac anomalies in IDDM. Tamura and Dooley, (1991). Becerra (1990) reports a relative risk of 18 for cardiovascular anomalies associated with IDDM, with an absolute risk of 8.5/100 live births. Others report a 2-4 times increased risk for CHD, with the severity and duration of the diabetes impacting on the rate. Rowland et al (1973) found as many as 4% of infants born to diabetic mothers have CHD. Mary C.M. Macintosh found CHD 3.4 times than in general population.
Rate of birth defect among women with poor control ranges from [4.5%-35.3%], However, with good glycaemic control. The study of Mary C M Macintoshet al 17 showed that it was similar to that of nondiabetic group. As diabetic embriopathy occurs at early gestational age [4-7 wks after conception], periconceptional blood sugar control is obligatory.
